CLCGY
Clicks Group Limited [CLCGY] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
CLCGY Stock Summary
In the News
CLCGY Financial details
Company Rating
Strong Buy
Market Cap
3.58B
Income
-
Revenue
-
Book val./share
49.09
Cash/share
20.2
Dividend
0.73
Dividend %
0.11%
Employees
17.87K
Optionable
No
Shortable
Yes
Earnings
-
P/E
30.87
Forward P/E
-
PEG
-
P/S
1.84
P/B
13.13
P/C
1.49
P/FCF
32.19
Quick Ratio
0.23
Current Ratio
1.1
Debt / Equity
0.54
LT Debt / Equity
0.36
-
-
EPS (TTM)
-
EPS next Y
-
EPS next Q
-
EPS this Y
-1.14%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
8.81%
Revenue last 5Y
5.83%
Revenue Q/Q
3%
EPS Q/Q
12.96%
-
-
-
-
SMA20
-0.54%
SMA50
-8.32%
SMA100
19.03%
Inst Own
0%
Inst Trans
0%
ROA
13%
ROE
44%
ROC
0.44%
Gross Margin
22%
Oper. Margin
9%
Profit Margin
6%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
24.1-36.16
52W High
-16.47%
52W Low
+25.29%
RSI
39.35
Rel Volume
0.72
Avg Volume
572
Volume
414
Perf Week
-1.28%
Perf Month
-5.88%
Perf Quarter
-
Perf Half Y
8.4%
-
-
-
-
Beta
0.173
-
-
Volatility
0.67%, 0.75%
Prev Close
-3.25%
Price
30.07
Change
-3.25%
CLCGY Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-08-31
| Metric | History | 2019-08-31 | 2020-08-31 | 2021-08-31 | 2022-08-31 | 2023-08-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 251.7 | 274.68 | 302.24 | 324.09 | 341.92 | |
| Net income per share | 13.5 | 15.03 | 14.88 | 21.6 | 20.85 | |
| Operating cash flow per share | 15.13 | 12.12 | 18.71 | 15.69 | 27.19 | |
| Free cash flow per share | 9.94 | 7.4 | 13.13 | 8.84 | 19.55 | |
| Cash per share | 20.98 | 17.21 | 17.86 | 16.49 | 20.17 | |
| Book value per share | 39.44 | 41.52 | 38.9 | 46.65 | 49 | |
| Tangible book value per share | 34.62 | 36.15 | 32.64 | 39.91 | 39.36 | |
| Share holders equity per share | 39.44 | 41.52 | 38.9 | 46.65 | 49 | |
| Interest debt per share | 8.58 | 23.35 | 25.44 | 27.1 | 28.51 | |
| Market cap | 49.68B | 58.9B | 71.63B | 76.45B | 67.81B | |
| Enterprise value | 47.26B | 59.43B | 72.34B | 77.53B | 68.6B | |
| P/E ratio | 29.55 | 31.33 | 38.97 | 28.97 | 26.72 | |
| Price to sales ratio | 1.58 | 1.71 | 1.92 | 1.93 | 1.63 | |
| POCF ratio | 26.35 | 38.83 | 30.98 | 39.88 | 20.49 | |
| PFCF ratio | 40.11 | 63.61 | 44.16 | 70.82 | 28.49 | |
| P/B Ratio | 10.11 | 11.34 | 14.91 | 13.41 | 11.37 | |
| PTB ratio | 10.11 | 11.34 | 14.91 | 13.41 | 11.37 | |
| EV to sales | 1.51 | 1.73 | 1.94 | 1.96 | 1.65 | |
| Enterprise value over EBITDA | 16.94 | 14.81 | 17.24 | 16.32 | 13.1 | |
| EV to operating cash flow | 25.07 | 39.18 | 31.29 | 40.44 | 20.72 | |
| EV to free cash flow | 38.16 | 64.19 | 44.6 | 71.82 | 28.82 | |
| Earnings yield | 0.03 | 0.03 | 0.03 | 0.03 | 0.04 | |
| Free cash flow yield | 0.02 | 0.02 | 0.02 | 0.01 | 0.04 | |
| Debt to equity | 0.21 | 0.52 | 0.61 | 0.54 | 0.54 | |
| Debt to assets | 0.08 | 0.18 | 0.17 | 0.17 | 0.17 | |
| Net debt to EBITDA | -0.87 | 0.13 | 0.17 | 0.23 | 0.15 | |
| Current ratio | 1.3 | 1.2 | 1.1 | 1.15 | 1.1 | |
| Interest coverage | 97.68 | 11.73 | 13.15 | 17.36 | 15.64 | |
| Income quality | 0.8 | 0.59 | 0.91 | 0.53 | 0.95 | |
| Dividend Yield | 0.02 | 0.01 | 0.02 | 0.02 | 0.02 | |
| Payout ratio | 0.58 | 0.44 | 0.8 | 0.49 | 0.62 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.05 | 0.04 | 0.05 | 0.05 | 0.06 | |
| Capex to operating cash flow | -0.34 | -0.39 | -0.3 | -0.44 | -0.28 | |
| Capex to revenue | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 | |
| Capex to depreciation | -1.62 | -0.5 | -0.55 | -0.61 | -0.61 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 109.44 | 118.48 | 114.1 | 150.59 | 151.6 | |
| ROIC | 0.27 | 0.19 | 0.2 | 0.22 | 0.21 | |
| Return on tangible assets | 0.13 | 0.13 | 0.11 | 0.15 | 0.14 | |
| Graham Net | -14.05 | -32.38 | -46.27 | -47.66 | -42.68 | |
| Working capital | 2.35B | 1.6B | 1.04B | 1.45B | 1.03B | |
| Tangible asset value | 4.31B | 4.52B | 4.03B | 4.88B | 4.79B | |
| Net current asset value | 1.96B | -336.56M | -1.13B | -792.25M | -1.24B | |
| Invested capital | 0.21 | 0.52 | 0.61 | 0.54 | 0.54 | |
| Average receivables | 948.39M | 1.89B | 2.09B | 1.98B | 2.34B | |
| Average payables | 5.34B | 5.4B | 6.08B | 6.59B | 7.72B | |
| Average inventory | 4.47B | 4.82B | 5.19B | 5.81B | 6.24B | |
| Days sales outstanding | 22.08 | 20.06 | 22.42 | 15.32 | 26.48 | |
| Days payables outstanding | 83.89 | 68.98 | 85.22 | 72.28 | 104.72 | |
| Days of inventory on hand | 69.71 | 66.14 | 66.15 | 72.22 | 71.29 | |
| Receivables turnover | 16.53 | 18.19 | 16.28 | 23.82 | 13.78 | |
| Payables turnover | 4.35 | 5.29 | 4.28 | 5.05 | 3.49 | |
| Inventory turnover | 5.24 | 5.52 | 5.52 | 5.05 | 5.12 | |
| ROE | 0.34 | 0.36 | 0.38 | 0.46 | 0.43 | |
| Capex per share | -5.19 | -4.72 | -5.58 | -6.86 | -7.64 |
Quarterly Fundamentals Overview
Last date of statement is 2023-08-31 for Q4
| Metric | History | 2022-08-31 | 2022-11-30 | 2023-02-28 | 2023-05-31 | 2023-08-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 11.19 | 0 | 9.94 | 0 | 10.28 | |
| Net income per share | 0.74 | 0 | 0.54 | 0 | 0.61 | |
| Operating cash flow per share | 1.34 | 0 | 0.46 | 0 | 1.7 | |
| Free cash flow per share | 1.09 | 0 | 0.29 | 0 | 1.52 | |
| Cash per share | 16.51 | 0 | 9.47 | 0 | 20.2 | |
| Book value per share | 46.72 | 0 | 46.95 | 0 | 49.09 | |
| Tangible book value per share | 39.96 | 0 | 40.29 | 0 | 39.43 | |
| Share holders equity per share | 46.72 | 0 | 46.95 | 0 | 49.09 | |
| Interest debt per share | 25.47 | 0 | 26.54 | 0 | 26.71 | |
| Market cap | 76.34B | 0 | 65.5B | 0 | 67.7B | |
| Enterprise value | 77.43B | -1.16B | 67.58B | -2.46B | 68.48B | |
| P/E ratio | 211.6 | 0 | 249.83 | 0 | 226.48 | |
| Price to sales ratio | 55.92 | 0 | 54.02 | 0 | 54.2 | |
| POCF ratio | 468.33 | 0 | 1.18K | 0 | 326.9 | |
| PFCF ratio | 572.43 | 0 | 1.83K | 0 | 366.44 | |
| P/B Ratio | 13.4 | 0 | 11.44 | 0 | 11.35 | |
| PTB ratio | 13.4 | 0 | 11.44 | 0 | 11.35 | |
| EV to sales | 56.71 | 0 | 55.73 | 0 | 54.83 | |
| Enterprise value over EBITDA | 436.93 | 0 | 497.19 | 0 | 461.16 | |
| EV to operating cash flow | 474.98 | 0 | 1.21K | 0 | 330.68 | |
| EV to free cash flow | 580.57 | 0 | 1.89K | 0 | 370.68 | |
| Earnings yield | 0 | 0 | 0 | 0 | 0 | |
| Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
| Debt to equity | 0.54 | 0 | 0.56 | 0 | 0.54 | |
| Debt to assets | 0.17 | 0 | 0.19 | 0 | 0.17 | |
| Net debt to EBITDA | 6.12 | 0 | 15.27 | 0 | 5.28 | |
| Current ratio | 1.15 | 1.15 | 1.15 | 1.1 | 1.1 | |
| Interest coverage | 19.79 | 0 | 15.15 | 0 | 16.08 | |
| Income quality | 1.81 | 0 | 0.85 | 0 | 2.77 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0.28 | 0 | 0.97 | 0 | 0.28 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.05 | 0.05 | 0.05 | 0.06 | 0.06 | |
| Capex to operating cash flow | -0.18 | 0 | -0.36 | 0 | -0.11 | |
| Capex to revenue | -0.02 | 0 | -0.02 | 0 | -0.02 | |
| Capex to depreciation | -0.67 | 0 | -0.47 | 0 | -0.54 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 27.88 | 0 | 23.83 | 0 | 26.06 | |
| ROIC | 0.01 | 0 | 0.01 | 0 | 0.01 | |
| Return on tangible assets | 0.01 | 0 | 0 | 0 | 0 | |
| Graham Net | -47.73 | 0 | -41.11 | 0 | -42.75 | |
| Working capital | 1.45B | 1.44B | 1.44B | 1.03B | 1.03B | |
| Tangible asset value | 4.88B | 4.91B | 4.91B | 4.79B | 4.79B | |
| Net current asset value | -792.25M | -873.59M | -873.59M | -1.24B | -1.24B | |
| Invested capital | 0.54 | 0 | 0.56 | 0 | 0.54 | |
| Average receivables | 1.66B | 2.31B | 2.96B | 2.99B | 3.02B | |
| Average payables | 6.17B | 7.12B | 8.07B | 8.67B | 9.27B | |
| Average inventory | 6.16B | 6.43B | 6.69B | 6.5B | 6.31B | |
| Days sales outstanding | 109.56 | 0 | 219.56 | 0 | 217.58 | |
| Days payables outstanding | 537.82 | 0 | 785.58 | 0 | 883.01 | |
| Days of inventory on hand | 537.39 | 0 | 651.32 | 0 | 601.11 | |
| Receivables turnover | 0.82 | 0 | 0.41 | 0 | 0.41 | |
| Payables turnover | 0.17 | 0 | 0.11 | 0 | 0.1 | |
| Inventory turnover | 0.17 | 0 | 0.14 | 0 | 0.15 | |
| ROE | 0.02 | 0 | 0.01 | 0 | 0.01 | |
| Capex per share | -0.24 | 0 | -0.16 | 0 | -0.18 |
CLCGY Frequently Asked Questions
What is Clicks Group Limited stock symbol ?
Clicks Group Limited is a ZA stock and trading under the symbol CLCGY
What is Clicks Group Limited stock quote today ?
Clicks Group Limited stock price is $30.07 today.
Is Clicks Group Limited stock public?
Yes, Clicks Group Limited is a publicly traded company.
Company Profile
- Volume Average 572
- Market Capitalization 3.58B
- Employee 17.87K
- CEO Ms. Bertina D. Engelbrecht B.Proc, LLM
- Headquarters Cape Town,ZA
- IPO Date 2010-06-07
-
Website
https://www.clicksgroup.co.za 
Clicks Group Limited, together with its subsidiaries, operates as a health and beauty retailer, and pharmaceutical distributor and wholesaler in South Africa. The company operates in two segments, Retail and Distribution. It retails pharmacy, health and beauty through approximately 840 stores, and 620 in-store pharmacies for the middle to upper income markets under the Clicks name. The company also retails specialty health and wellness products, including vitamins, mineral and herbal supplements, sports nutrition, and slimming products under the General Nutrition Corporation (GNC) name; luxury toiletries, cosmetics, gifting, and grooming products under The Body Shop name; and fashionable jewelry and accessories for young women and girls under the Claire's name. In addition, it is involved in the wholesale and supply of pharmaceutical products to retail pharmacies, private hospitals, dispensing doctors, and retail health stores under the UPD name. The company was formerly known as New Clicks Holdings Limited and changed its name to Clicks Group Limited in June 2009. Clicks Group Limited was founded in 1968 and is based in Cape Town, South Africa.
